Technical Analysis for GENF - Genflow Biosciences plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| 20 DMA Resistance | Bearish | 4.84% | |
| NR7 | Range Contraction | 4.84% | |
| Narrow Range Bar | Range Contraction | 4.84% | |
| Fell Below 20 DMA | Bearish | 4.84% | |
| Narrow Range Bar | Range Contraction | 4.84% | |
| 50 DMA Support | Bullish | 4.84% | |
| MACD Bearish Signal Line Cross | Bearish | 4.84% | |
| 20 DMA Support | Bullish | 4.84% | |
| Boomer Buy Setup | Bullish Swing Setup | 4.84% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 18 hours ago |
| Outside Day | about 18 hours ago |
| Up 5% | about 18 hours ago |
| 10 DMA Support | about 19 hours ago |
| Rose Above 10 DMA | about 19 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Genflow Biosciences plc operates as a biotechnology company that focuses on developing therapies to counteract the effects of aging and diseases associated with advanced age. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. The company was incorporated in 2021 and is headquartered in London, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Branches Of Biology Diseases Biology Molecular Biology Gene Therapy Gene Delivery Bioethics Viral Vector Virotherapy
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Branches Of Biology Diseases Biology Molecular Biology Gene Therapy Gene Delivery Bioethics Viral Vector Virotherapy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.25 |
| 52 Week Low | 1.3225 |
| Average Volume | 897,981 |
| 200-Day Moving Average | 1.77 |
| 50-Day Moving Average | 1.51 |
| 20-Day Moving Average | 1.57 |
| 10-Day Moving Average | 1.58 |
| Average True Range | 0.13 |
| RSI (14) | 58.85 |
| ADX | 35.47 |
| +DI | 21.00 |
| -DI | 8.70 |
| Chandelier Exit (Long, 3 ATRs) | 1.45 |
| Chandelier Exit (Short, 3 ATRs) | 1.71 |
| Upper Bollinger Bands | 1.73 |
| Lower Bollinger Band | 1.40 |
| Percent B (%b) | 0.68 |
| BandWidth | 21.41 |
| MACD Line | 0.02 |
| MACD Signal Line | 0.02 |
| MACD Histogram | -0.0024 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.77 | ||||
| Resistance 3 (R3) | 1.76 | 1.71 | 1.74 | ||
| Resistance 2 (R2) | 1.71 | 1.67 | 1.71 | 1.74 | |
| Resistance 1 (R1) | 1.67 | 1.65 | 1.69 | 1.67 | 1.73 |
| Pivot Point | 1.61 | 1.61 | 1.62 | 1.61 | 1.61 |
| Support 1 (S1) | 1.57 | 1.57 | 1.59 | 1.58 | 1.52 |
| Support 2 (S2) | 1.52 | 1.55 | 1.52 | 1.51 | |
| Support 3 (S3) | 1.48 | 1.52 | 1.51 | ||
| Support 4 (S4) | 1.48 |
